Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
2022 · Experimental Hematology and Oncology · 36 citations
https://doi.org/10.1186/s40164-022-00296-9
S
Shunjie Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
152
Citations
7
h-index
4
i10-index
Shunjie Yu is an academic researcher from Peking University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 7, co-authored 13 publications.
ORCID: 0000-0001-6187-9918Papers by this author
works<scp>TIM3</scp>/<scp>CEACAM1</scp> pathway involves in myeloid‐derived suppressor cells induced <scp>CD8</scp><sup>+</sup> T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome
2022 · Immunology · 33 citations
https://doi.org/10.1111/imm.13488
Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
2023 · Heliyon · 3 citations
https://doi.org/10.1016/j.heliyon.2023.e19222
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat